Business
BioSpectrum Asia
"ASEAN has become an important fulcrum in the global pharmaceutical production supply chain"
Asia-based BioDlink, a full-service Contract Development and Manufacturing Organisation (CDMO) specialising in biologics and antibody-drug conjugates (ADCs), has built a strong track record over the past decade, offering integrated solutions from early-stage R&D to commercial manufacturing.
4 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
India approves Research Development and Innovation scheme with corpus of Rs 1 lakh cr
In a transformative step to bolster India's research and innovation ecosystem, the Union Cabinet, chaired by Prime Minister Narendra Modi, has approved the Research Development and Innovation (RDI) Scheme with a corpus of Rs one lakh crore.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
New Zealand enables GPs and nurse practitioners to start ADHD treatment from 2026
From February 2026, General practitioners (GPS) and nurse practitioners will be able to start medical treatment for adults with Attention Deficit Hyperactivity Disorder (ADHD), following decisions by New Zealand Medicines and Medical Devices Safety Authority and Pharmaceutical Management Agency.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Indonesia's Health Ministry inks MoU with Philips to strengthen long-term health system resilience
Royal Philips, a global leader in health technology, and Indonesia's Ministry of Health have signed Memorandum of Understanding (MoU) to strengthen the transformation of Indonesia's healthcare system through clinical capacity development, digital health innovation, and the development of training centre and service hub.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Martin Fischer steps in as President and CEO of Zeiss Greater China
Zeiss Group, an expert in Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets, has announced that Martin Fischer will officially take on the role of President and CEO of Zeiss Greater China, effective from October 1, 2025, reporting directly to Andreas Pecher, President and CEO of the Zeiss Group.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Korea-Israel partnership to commercialise injectable treatment for focal fat reduction
365mc, South Korea's leading medical institution specialising in fat reduction treatments, and Israel-based Raziel Therapeutics, a global clinical-stage biopharmaceutical company, have announced a strategic collaboration to jointly advance the clinical and commercial development of RZL-012 in South Korea.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Country wise analysis of startups with funds raising
Asia-Pacific is home to 9,905 active life sciences startups, as of July 20, 2025, according to Tracxn. Of these, 4,289 have secured funding, and 1,840 have advanced to Series A or later stages.
2 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
China approves world's first dual GCG/GLP-1 receptor agonist for weight loss
Innovent Biologics, Inc. has announced that China's National Medical Products Administration (NMPA) has approved mazdutide a first-in-class dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, for chronic weight management in Chinese adults with overweight or obesity.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Indian firm Biological E partners with China's Recbio to produce HPV9 vaccine
Jiangsu Recbio Technology, a leading Chinese biopharmaceutical company, has entered into a licensing cooperation agreement, and have commenced the technology transfer of their Recombinant 9-valent HPV (HPV9) vaccine, REC603, to Biological E.Limited BE, a leading Indian vaccine and pharmaceutical company.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Bio-Rad launches four new Droplet Digital PCR platforms
Bio-Rad Laboratories, Inc. , a global leader in life science research and clinical diagnostics products, has announced the launch of four new Droplet Digital PCR (ddPCR) platforms.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
AN Venture Partners announces one of the largest Japan focused biotech funds to date
AN Venture Partners (ANV), a global biotech venture capital firm, has announced the final close of its first fund, AN Venture Partners I, LP, achieving its target of $200 million (JPY29 billion), one of the largest Japan-focused biotech venture capital funds to date, and also one of the largest first-time biotech venture capital funds raised in the past year.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Bio-Rad launches four new Droplet Digital PCR platforms
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, has announced the launch of four new Droplet Digital PCR (ddPCR) platforms.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Africa to decentralise diagnostics and accelerate outbreak response
In a major step toward faster and more localised outbreak response, Africa Centres for Disease Control and Prevention (CDC) convened public health leaders from ten African countries in Yaoundé to co-develop a continental framework for decentralising laboratory services.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Agilent launches InfinityLab Pro iQ Series Mass Detectors in India
Agilent Technologies has launched its InfinityLab Pro iQ Series mass detectors in India.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Singapore pilots innovative approach to diabetic foot care through 3D-printed custom insoles
Sengkang General Hospital (SKH) has piloted an innovative approach to diabetic foot care through in-house production of 3D-printed custom insoles in a cross-institution collaboration with Singapore General Hospital's (SGH) 3D printing centre.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Chugai and Gero ink $250 M deal to develop new therapies for age-related diseases
Japan's Chugai Pharmaceutical and Gero, a Singaporebased biotechnology company, have entered into a joint research and license agreement to develop novel therapies for age-related diseases.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Australia injects nearly A$100 M in funding for emerging biomedical & medical technology solutions
The Albanese Government has awarded nearly A$100 million in funding to three organisations for emerging Australian biomedical and medical technology innovations.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
PAHO launches dashboard to monitor respiratory viruses in the Americas
The Pan American Health Organization (PAHO) has launched a new interactive dashboard to enhance monitoring and analysis of respiratory virus circulation trends across the Americas, with the goal of strengthening surveillance and facilitating timely analysis of regional trends.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Korean study proposes toxicity-based exposure limits for indoor airborne fungi
Airborne microorganisms, including fungi and bacteria, are major contributors to indoor air pollution, with growing links to respiratory diseases.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
US expands access to lifesaving gene therapies
The Centers for Medicare & Medicaid Services (CMS) in the US has announced that 33 states, plus the District of Columbia and Puerto Rico, will participate in the Cell and Gene Therapy (CGT) Access Model, a bold new approach to delivering cutting-edge treatments for people on Medicaid living with sickle cell disease.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Biotech's Resurgence: Innovation Amid Market Disruption or A Generational Opportunity in Innovation
The biotechnology sector is showing signs of a resurgence. After several years of underperformance particularly among small and mid-cap companies, a convergence of scientific breakthroughs, shifting market dynamics, and growth in investor sentiment, is setting the stage for a potentially compelling recovery.
3 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Indonesia's Health Ministry inks MoU with Philips to strengthen long-term health system resilience
Royal Philips, a global leader in health technology, and Indonesia's Ministry of Health have signed Memorandum of Understanding (MoU) to strengthen the transformation of Indonesia's healthcare system through clinical capacity development, digital health innovation, and the development of training centre and service hub.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
DeepTek AI solution gains WHO recommendation in global fight against TB
Indian startup DeepTek, a leading medical imaging AI company, has received a significant recommendation from the World Health Organization (WHO) for its Chest X-ray AI solution for TB screening.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
WHO maps application of AI in traditional medicine
In a significant milestone for global healthcare innovation, the World Health Organization (WHO) has released a technical brief titled \"Mapping the Application of Artificial Intelligence in Traditional Medicine\", acknowledging India's pioneering efforts in integrating Artificial Intelligence (AI) with traditional medicine systems, particularly Ayush systems.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
New Zealand enables GPs and nurse practitioners to start ADHD treatment from 2026
From February 2026, General practitioners (GPs) and nurse practitioners will be able to start medical treatment for adults with Attention Deficit Hyperactivity Disorder (ADHD), following decisions by New Zealand Medicines and Medical Devices Safety Authority and Pharmaceutical Management Agency.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
New vaccine set for human trials in Nipah outbreak hotspot
A promising vaccine candidate against one of the world’s most deadly viruses, Nipah, is ready for testing in mid-stage human trials in Bangladesh, where people now die almost every year in Nipah disease outbreaks.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Singapore pledges contribution of $1 M to Gavi for better access to vaccines
The Singapore government has pledged a contribution of $1 million to Gavi, the Vaccine Alliance.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
India approves Research Development and Innovation scheme with corpus of Rs 1 lakh cr
In a transformative step to bolster India's research and innovation ecosystem, the Union Cabinet, chaired by Prime Minister Narendra Modi, has approved the Research Development and Innovation (RDI) Scheme with a corpus of Rs one lakh crore.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Restore Medical secures $23 M to advance medical device for heart failure therapy
Restore Medical, a clinical-stage medtech startup based in Israel, developing transcatheter therapies for heart failure, has announced the successful closing of a $23 million Series B financing round.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Waters and BD's Biosciences & Diagnostic Solutions business to merge into one
US-based Waters Corporation and BD (Becton, Dickinson and Company) have announced a definitive agreement to combine BD's Biosciences & Diagnostic Solutions business with Waters, creating an innovative life science and diagnostics leader with pioneering technologies and an industry-leading financial outlook.
1 min |